chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received Moderna COVID-19 vaccine on 4/30/21. Patient reports that 5 days after receiving vaccine he had severe bruising on left lateral thigh and knee. He went to hospital and had ultrasound which was inconclusive. Doctor recommended CT scan which he did not have. Patient reports that 9 days post-immunization he coughed up what he described as clot and/or tissue. He states that the bruising has resolved but he is still experiencing pain and numbness in affected thigh. He has had no history of CV events or clotting. He has had no additional follow-up with doctor or prescribed medications for adverse event.
Information has been received from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. In 2012, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance for the long term prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 15-NOV-2013, the patient was treated at a hospital for the onset of severe vesicular rash, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX, for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Information has been received from a registered nurse concerning a 21 year old white female with no known drug allergies or illness at the time of vaccination who on 01 Jan 2007 was vaccinated in the right deltoid with a 0.5 mL first dose of Gardasil. Concomitant therapy included Yaz, Zelnorm and Miralax. On 04 Jan 2007, the patient became lightheaded and had to lie down after receiving Gardasil vaccination. The patient stated that she had gotten lightheaded after injections in the past. She also did not have much to eat that morning. The patient did not lose consciousness and remained alert and responsive. The patient was given some peanut butter crackers and coke and subsequently felt better and recovered. Additional information is not expected.
Approximately 12 hours after the vaccine, I stayed in bed for 36 hours, fever just above/below 101, some body aches for the first 12 hours.  When fever broke, all was normal.
Information has been received from a physician concerning an 8 year old female who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck).  Reported to physician on 03/13/2004 and the physician noted that this was a moderate case of generalized varicella (also described as chickenpox breakthrough).  It was noted that the patient had over 50 lesions as part of the condition.  Subsequently, the patient recovered.
Injection site area (outside right bicep) was inflamed, red and itchy. Inflammation site size approx 4" in length and 2" in height.  Patient stated she noticed inflamation on 03/13/1022. Patient states symptoms have decreased. Not as red, inflamed and itchy.
redness of upper arm and bruising at site of injection right deltoid, and feeling of being ill and short of breath
PATIENT HAD NO REACTION RIGHT AFTER VACCINE WAS ADMINISTERED AND ROUGHLY 20 MINUTES LATER HAD FLUSHING SHAKINESS AND FELT LIKE MAYBE SHE WOULD PASS OUT BECAUSE OF THE UNEASY FEELING - EMS CAME AND TOOK HER TO HOSPITAL BUT DOCTOR WAS NOT SURE WHY SHE HAD REACTION -- NO ALLERGIES TO MEDICATIONS.
Pe state her left corner of her mouth is "tinging" pt states the same thing happened with first dose vaccine but this time "was worse". Pt refused Benadryl at first. Pt denied shortness of breath. Vitals at time of report 136/83. 1700 vitals 142/73. 1702 pt took Benadryl 25mg PO. at 1710 137/77  pt declined any further treatment and was released ambulator
I have had the WORST body aches ever. My Joints hurt, even my nuckles in my hand. The pain was so bad I could not rest well. I had a hard time moving around and am still having problems. Lost my appitie for a couple of days and then feel rough.
Pt recvd HIB vax on 22OCT91 & on 29NOV91 pt had redness & pain @ inject site & swelling the size of a golf ball; tx Cefaclor; @ time of report pt recovered;
pt recv vax; w/in 24 hr p/ vax,exp n,v, & d;may have also exp flu like sx, shortness of breath & abd cramps; w/in 2-3 days sx resolved;
Gave pt the full 0.5 ml dose vs. 0.25 ml booster dose during am clinic.  Discussed possible side effects with pt later on phone who was not concerned.
Medical assistant diluting covid vaccines diluted the vaccine with sterile water instead of sodium chloride. She followed the rest of the steps of preparing the vaccine correctly other than what to dilute the vaccine with. It was not caught until a few month later that this MA had been diluting the covid vaccines with the incorrect diluent. Therefore many patients, including this patient, received the covid vaccine with the incorrect diluent. Pfizer, the manufacturer, was contact regarding this and no data is available if the incorrect diluent type is supported to be stable. Therefore this dose with the incorrect diluent should be considered invalid and should be repeated. Patient was seen at acute care 2 days after the vaccination for laceration of the eyelid and he was not showing any signs or symptoms of an adverse reaction from the vaccine. He was seen on 11/02/2022 for fever and cough. He tested negative for covid, but positive for RSV.
Site of injection became sore upon injection  Increased and painful soreness within 4 hours with other muscular involvement at shoulder and elbow joint? nerve and pain of forearm and hand by 2am 4/3/21?severe
Next day, when showering in the morning saw left part of arm swollen like a bee bite and itchy.
This spontaneous report was received from a medical assistant and refers to multiple patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. On an unknown dates, the patients' were vaccinated with improperly stored GARDASIL 9 (dose, strength, route, frequency, lot # and indication unknown). The vaccine was exposed to a high of 9.5 degree Celsius temperature for a time frame of 24 hours. No adverse events were reported. Data logger was involved. It was reported that there was no previous temperature excursion. No product quality complaint was involved. This is one of the several reports received from the same reporter. Additional information has been requested.
postherpetic neuralgia; herpes zoster; Information was received from a lawyer regarding a case in litigation involving a male patient of unknown age. On an unknown date, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, lot # and expiration date were not reported) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unknown date, shortly after receiving the vaccine the patient was suffered herpes zoster and postherpetic neuralgia. As a result of these symptoms, the patient was seen and treated by medical providers and was still under their care. As a direct and proximate result of receiving zoster vaccine live (ZOSTAVAX) the patient's symptoms had resulted in physical limitations not present prior to using the product. The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of condition. As a result of zoster vaccine live (ZOSTAVAX) the patient suffered severe and permanent personal injuries. Further, as a tragic consequence of zoster vaccine live (ZOSTAVAX), the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events was considered to be not recovered. The causality of the events was considered to be related to zoster vaccine live (ZOSTAVAX). The events of herpes zoster and postherpetic neuralgia were considered as disabling.
I felt dizzy 45 mins after having my vaccine and i had a headache for 7 days straight and now it comes and goes. i have had fatigue and my blood pressure shot up and my cholesterol went up after having vaccine and now I am having to be on meds to control it
Mom called 5/1/09, c/o pain. "limping".  Temp 103 degrees during the night, shaking, Temp 102 degrees am of 5/1/09 c/o tummy ache, gagging, 0 vomiting temp decreased with TYLENOL.  Ok over the weekend fine today 5/4/09.
Chest heaviness in center of the chest, cant take a deep breath, evaluated by EMS-cleared
Patient arm has red blotch that is spreading, warm to touch, tender at touch, no major pain, no itching
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 12/31/21pfizer,Lot#EL0142 2nd dose: 01/21/21,Pfizer,Lot# EL3247 Diagnosed covid positive:07/23/21 SYMPTOMS BEGAN:07/20/21 Exposure:Unknown Symptoms:Cough, fatigue
I can feel a clot in arm making it very painful; My left arm has been in pain; I cannot use my left arm.; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 53-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 23Apr2021 11:00 (Lot Number: EW0172) as single dose for covid-19 immunisation at 53 years old. The patient medical history was not reported. Concomitant medication(s) included lisinopril (unknown manufacturer, 5 mg) taken for an unspecified indication, start and stop date were not reported. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EP6955) on 27Mar2021 at 10:00 in left arm when 53 years old. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced can feel a clot in arm making it very painful (thrombosis) (medically significant), his left arm has been in pain (pain in extremity) (non-serious) and cannot use his left arm (mobility decreased) (non-serious) on 23Apr2021 with outcome of not recovered. The patient reported that his left arm has been in pain since the time of injection and now he can feel a clot in arm making it very painful and he cannot use his left arm. The patient was not treated for the events. The patient did not have COVID-19 prior to vaccination and was not covid tested post vaccination.  Information on Lot/Batch number was available. Additional information has been requested.
next day area appeard red mild swollen and itchy.  It stayed that way for 4-5 days and then disappeared.   On 1/18/2021 the area was severely red and big hive was noted surrounding site of injection.  Severe itchiness still present.
tongue tingles; jaw swollen; This case was reported by a consumer via call center representative and described the occurrence of tingling tongue in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously experienced adverse reactions included food allergy.   On 14th November 2019, the patient received the 1st dose of Shingrix. On 15th November 2019, 1 days after receiving Shingrix, the patient experienced tingling tongue and facial swelling. On an unknown date, the outcome of the tingling tongue and facial swelling were unknown.   It was unknown if the reporter considered the tingling tongue and facial swelling to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not provided. The patient received Shingrix and the morning after, the patient experienced tingling in her tongue and a swollen jaw. The patient reported that she contracted a tick borne condition that makes her allergic to ingesting mammalian derived items. The patient did not wish to participate in a safety report without consulting with doctor.
Pt has been experiencing severe arm pain. He is unable to move his arm in any direction and the pain radiates down to his wrist.  The pain has been going on for a week after his vaccine. He has a doctor's appointment on 11/5/21 and was counseled to discuss with his doctor.
24 hrs after inject arm became reddened large whelt silver dollar in size red-itchy and sore to touch lasting 4 days.
Information has been received from a pharmacist concerning a 28 year old female patient. The patient's concurrent condition, medical history and concomitant therapy were not reported. On approximately 11-DEC-2018, reported as about a week ago, the patient was vaccinated with a dose of M-M-R II (dose, unit not reported, lot # R022582 with expiration date of 07-AUG-2020 (also reported as 17-AUG-2020), therapy type: rHA), via intramuscular (Incorrect route of product administration) for prophylaxis. No adverse effects were reported.
pain during lifting of arm/painful; Her arm was sore; This spontaneous case was reported by a nurse and describes the occurrence of MOBILITY DECREASED (pain during lifting of arm/painful) and PAIN IN EXTREMITY (Her arm was sore) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Humerus fracture (broke the head of the humerus of her left arm). Concurrent medical conditions included Allergy (long-standing nickel allergy from foods).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MOBILITY DECREASED (pain during lifting of arm/painful) and PAIN IN EXTREMITY (Her arm was sore). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency and IBUPROFEN for Pain, at an unspecified dose and frequency. At the time of the report, MOBILITY DECREASED (pain during lifting of arm/painful) and PAIN IN EXTREMITY (Her arm was sore) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   She went through many years of physical therapy as she couldn't lift her arm.   Upon follow-up she stated  that her left shoulder has become so painful it was affecting the nerve tissue all the way down her arm, down to her thumb. At that point, on the top of her thumb,the nerve has made her thumb bend in a strange way. She was still alternating between Tylenol and Ibuprofen. The pain was not constant it depends on how she moved her body or if she shifts her arm in the wrong way. The pain started in the deltoid and not the scapula. She thought it was originally irritated by the needle.     Most recent FOLLOW-UP information incorporated above includes: On 04-Mar-2021: Reporter's address updated,  patient's history was added and 2 new events arthralgia and neuralgia were reported.
DTaP, IPV,MMR given on 12/1/2001. On 12/14/2001, pt's right thigh was red, warm, swollen and afebrile. He saw a doctor who prescribed Benadryl and repeat appointment.
took 2 doses of Moderna shot Mar and Apr and Pfizer Booster shot in Sep; took 2 doses of Moderna shot Mar and Apr and Pfizer Booster shot in Sep; 18 lb weight loss; voice changed to soft and horse; inflammation flare up in lower back; extreme fatigue; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 78-years-old male patient received third dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date in Sep2021 as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. The patient medical history included heart disease, Kidney disease, and arthritis from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Historical vaccine included first dose of moderna (MODERNA COVID-19 VACCINE, lot number and expiry date were not reported) via an unspecified route of administration, on an unspecified date in Mar2021, as dose 1, single  and second dose of moderna (MODERNA COVID-19 VACCINE, lot number and expiry date were not reported) via an unspecified route of administration, on an unspecified date in Apr2021, as dose 2, single for covid-19 immunisation. The patient took 2 doses of moderna shot in Mar and Apr and Pfizer booster shot in Sep2021. On an unspecified date, on 2021, the patient experienced 18 lb weight loss, voice changed to soft and horse, inflammation flare up in lower back and extreme fatigue. On an unspecified date, the patient underwent lab tests and procedures which included weight which was 18 lbs (weight loss). The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt recvd vax as part of routine 4 mos well baby visit; pt cried that evening but appeared fine, happy & nl next AM; parents found pt dead in crib that afternoon-SIDS death;
pt. remained alert/oriented x4 and exhibited/reported no pain/adverse symptoms/effects.  Monitored for 30mins post-administration and denied symptoms/questions/concerns.  No objective s/sx adverse rxn. noted.  Left clinic after observation period as entered-ambulatory per wheeled walker.
Felt dizzy 5 minutes post vaccination.  BP 137/74, HR 87, O2 sat 100%
dizzy; not in her "right mind"; weakness; speech impairment; Covid positive at one point; This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: unknown), via an unspecified route of administration, on 27Aug2021, 3:30PM (age at vaccination: 68), as dose 2, single for COVID-19 immunization. The patient medical history included very weak immune system. The patient's concomitant medications were not reported. Historical vaccine reported as BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: unknown), via an unspecified route of administration, on unspecified date as dose 1, single for COVID-19 immunization and had different reactions to both. The patient experienced dizzy, not in right mind, weakness and speech impairment and covid positive at one point . The patient underwent lab tests and procedures which included sars-cov-2 test: positive at one point. Outcome of all events was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Patient had no adverse event or outcome. After administration, it was discovered that vaccine refrigerator was out of temp range.  Pt is notified and offered re=vaccination.
Dose administered from punctured Moderna Covid-19 vaccine vial > 12 hours post puncture; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered from punctured Moderna Covid-19 vaccine vial > 12 hours post puncture) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 035221A and 035221A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered from punctured Moderna Covid-19 vaccine vial > 12 hours post puncture). On 22-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Dose administered from punctured Moderna Covid-19 vaccine vial > 12 hours post puncture) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were reported.
Develop bilateral nerve burning sensations from shoulders to fingers. Sensations was continuous and lasted for 3 days. Brain fog also developed and is still experiencing now. Memory loss, head feels heavy, difficulty thinking and recalling events, names or objects.
dizzy; Rash; Fever 101.8; vomiting; headache; weakness; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient. A 43-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 20Oct2021 11:00 (Lot number: FH2027) at the age of 43 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: NOTES-If Covid prior vaccination: Yes. The patient took concomitant medications. Past drug history included: Ropinirole, reaction(s): "known allergies: Ropinerole". The following information was reported: DIZZINESS (non-serious) with onset 20Oct2021 16:00, outcome "not recovered", described as "dizzy"; RASH (non-serious) with onset 20Oct2021 16:00, outcome "not recovered", described as "Rash"; PYREXIA (non-serious) with onset 20Oct2021 16:00, outcome "not recovered", described as "Fever 101.8"; VOMITING (non-serious) with onset 20Oct2021 16:00, outcome "not recovered", described as "vomiting"; HEADACHE (non-serious) with onset 20Oct2021 16:00, outcome "not recovered", described as "headache"; ASTHENIA (non-serious) with onset 20Oct2021 16:00, outcome "not recovered", described as "weakness". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of dizziness, rash, pyrexia, vomiting, headache, asthenia. Additional information The patient did not receive any other vaccine in four weeks. The patient received other medications in last two weeks.The patient had Covid prior vaccination. The patient had been tested for Covid post vaccination. Covid test type post vaccination was Nasal Swab. Covid test result was Negative  Follow-up attempts are completed. No further information is expected.